Literature DB >> 18815460

[Risk factors for early recurrence after surgical resection for hepatocellular carcinoma].

Ui Jun Park1, Yong Hoon Kim, Koo Jeong Kang, Tae Jin Lim.   

Abstract

BACKGROUND/AIMS: Early recurrence (ER) after liver resection is one of the most important factors impacting the prognosis and survival of patients with hepatocellular carcinoma (HCC). This study aimed to identify the factors associated with ER after curative hepatic resection for HCC.
METHODS: From the July 2000 to July 2006, 144 patients underwent hepatic resection for HCC at a single institution. After excluding those with ruptured HCC, combined or mixed HCC, and who died during admission, 116 patients were analyzed. Patients with ER (defined as within 1 year) were compared with those who remained free of disease for more than 1 year. Various clinical characteristics including tumor and operative factors were evaluated to determine the factors predicting postoperative ER using univariate and multivariate analyses.
RESULTS: ER occurred in 51 patients (44%). In the univariate analysis, tumor size (P=0.001), microvascular invasion (P=0.003), portal vein invasion (P=0.001), TNM stage (P=0.010), serum levels of alpha-fetoprotein (AFP) (P=0.002) and aspartate aminotransferase (AST) (P=0.011), and operative time (P=0.033) were significantly associated with ER. AFP and AST were the independent predictors of ER in the multivariate analysis (P<0.05).
CONCLUSIONS: Preoperative serum AFP and AST levels were the independent risk factors for ER after surgical resection for HCC. Close postoperative surveillance is recommended for early detection of recurrence and additional treatments in patients with these factors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815460     DOI: 10.3350/kjhep.2008.14.3.371

Source DB:  PubMed          Journal:  Korean J Hepatol        ISSN: 1738-222X


  8 in total

1.  Elevated serum alpha fetoprotein levels promote pathological progression of hepatocellular carcinoma.

Authors:  Peng Li; Shan-Shan Wang; Hui Liu; Ning Li; Michael A McNutt; Gang Li; Hui-Guo Ding
Journal:  World J Gastroenterol       Date:  2011-11-07       Impact factor: 5.742

2.  Diffusion-weighted imaging of hepatocellular carcinoma for predicting early recurrence and survival after hepatectomy.

Authors:  Ali Muhi; Tomoaki Ichikawa; Utaroh Motosugi; Katsuhiro Sano; Zareen Fatima; Masanori Matsuda; Hideki Fujii; Nobuyuki Enomoto; Tsutomu Araki
Journal:  Hepatol Int       Date:  2012-06-22       Impact factor: 6.047

3.  Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency ablation: analysis of risk factors.

Authors:  Hee Young Lee; Hyunchul Rhim; Min Woo Lee; Young-Sun Kim; Dongil Choi; Min Jung Park; Young Kon Kim; Seong Hyun Kim; Hyo Keun Lim
Journal:  Eur Radiol       Date:  2012-10-20       Impact factor: 5.315

4.  Is there an optimal staging system or liver reserve model that can predict outcome in hepatocellular carcinoma?

Authors:  Veeravich Jaruvongvanich; Tomoki Sempokuya; Linda Wong
Journal:  J Gastrointest Oncol       Date:  2018-08

5.  The survival benefit of liver transplantation for hepatocellular carcinoma patients with hepatitis B virus infection and cirrhosis.

Authors:  Qing Zhang; Xinguo Chen; Yunjin Zang; Li Zhang; Hong Chen; Letian Wang; Yujian Niu; Xiuyun Ren; Zhongyang Shen; Lei Shang
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

6.  Risk Factors for Intrahepatic Recurrence after Resection of Hepatocellular Carcinomas in Patients with Hepatitis B Virus Infection.

Authors:  Myung Hee Yoon; Young Il Choi; Kwang Kuk Park; Dong Hoon Shin; Chung Han Lee
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2011-05-31

7.  Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt.

Authors:  Asmaa Ibrahim Gomaa; Mohamed Saad Hashim; Imam Waked
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

8.  Prognostic Analysis of Postoperative Survival for Ruptured Hepatocellular Carcinoma with or without Cirrhosis.

Authors:  Feng Xia; Peng Zhu; Xiao-Ping Chen; Bi-Xiang Zhang; Ming-Yu Zhang
Journal:  J Oncol       Date:  2022-03-17       Impact factor: 4.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.